These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 26086392)

  • 1. Oseltamivir Prophylaxis Reduces Inflammation and Facilitates Establishment of Cross-Strain Protective T Cell Memory to Influenza Viruses.
    Bird NL; Olson MR; Hurt AC; Oshansky CM; Oh DY; Reading PC; Chua BY; Sun Y; Tang L; Handel A; Jackson DC; Turner SJ; Thomas PG; Kedzierska K
    PLoS One; 2015; 10(6):e0129768. PubMed ID: 26086392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of aloin on viral neuraminidase and hemagglutinin-specific T cell immunity in acute influenza.
    Huang CT; Hung CY; Hseih YC; Chang CS; Velu AB; He YC; Huang YL; Chen TA; Chen TC; Lin CY; Lin YC; Shih SR; Dutta A
    Phytomedicine; 2019 Nov; 64():152904. PubMed ID: 31454654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The administration of oseltamivir results in reduced effector and memory CD8+ T cell responses to influenza and affects protective immunity.
    Marois I; Cloutier A; Garneau É; Lesur O; Richter MV
    FASEB J; 2015 Mar; 29(3):973-87. PubMed ID: 25414485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Role of Influenza Virus Exposure History in Determining Pandemic Susceptibility and CD8+ T Cell Responses.
    Quiñones-Parra SM; Clemens EB; Wang Z; Croom HA; Kedzierski L; McVernon J; Vijaykrishna D; Kedzierska K
    J Virol; 2016 Aug; 90(15):6936-6947. PubMed ID: 27226365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral burden, inflammatory milieu and CD8
    Nüssing S; Mifsud E; Hensen L; Koutsakos M; Wang Z; Kedzierski L; Mercuri F; Rossignol JF; Hurt AC; Kedzierska K
    Influenza Other Respir Viruses; 2020 Nov; 14(6):678-687. PubMed ID: 32588557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential Viral-Host Immune Interactions Associated with Oseltamivir-Resistant H275Y and Wild-Type H1N1 A(pdm09) Influenza Virus Pathogenicity.
    Vidaña B; Martínez-Orellana P; Martorell JM; Baratelli M; Martínez J; Migura-Garcia L; Córdoba L; Pérez M; Casas I; Pozo F; Fraile L; Majó N; Montoya M
    Viruses; 2020 Jul; 12(8):. PubMed ID: 32721992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuraminidase Mutations Conferring Resistance to Oseltamivir in Influenza A(H7N9) Viruses.
    Marjuki H; Mishin VP; Chesnokov AP; De La Cruz JA; Davis CT; Villanueva JM; Fry AM; Gubareva LV
    J Virol; 2015 May; 89(10):5419-26. PubMed ID: 25740997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivated Influenza Vaccine That Provides Rapid, Innate-Immune-System-Mediated Protection and Subsequent Long-Term Adaptive Immunity.
    Chua BY; Wong CY; Mifsud EJ; Edenborough KM; Sekiya T; Tan AC; Mercuri F; Rockman S; Chen W; Turner SJ; Doherty PC; Kelso A; Brown LE; Jackson DC
    mBio; 2015 Oct; 6(6):e01024-15. PubMed ID: 26507227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of memory CD8+ T cells with live attenuated influenza virus across different vaccination doses.
    Wang Z; Kedzierski L; Nuessing S; Chua BYL; Quiñones-Parra SM; Huber VC; Jackson DC; Thomas PG; Kedzierska K
    J Gen Virol; 2016 Dec; 97(12):3205-3214. PubMed ID: 27902386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the efficacy of the neuraminidase inhibitor oseltamivir against 2009 pandemic H1N1 influenza virus in ferrets.
    Govorkova EA; Marathe BM; Prevost A; Rehg JE; Webster RG
    Antiviral Res; 2011 Aug; 91(2):81-8. PubMed ID: 21635924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recalling the Future: Immunological Memory Toward Unpredictable Influenza Viruses.
    Auladell M; Jia X; Hensen L; Chua B; Fox A; Nguyen THO; Doherty PC; Kedzierska K
    Front Immunol; 2019; 10():1400. PubMed ID: 31312199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Broadly Protective CD8
    Zhang H; Zheng H; Guo P; Hu L; Wang Z; Wang J; Ju Y; Meng S
    J Virol; 2021 May; 95(12):. PubMed ID: 33827939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virus load kinetics and resistance development during oseltamivir treatment in infants and children infected with Influenza A(H1N1) 2009 and Influenza B viruses.
    Rath B; von Kleist M; Tief F; Karsch K; Tuerk E; Muehlhans S; Louis F; Skopnik H; Schweiger B; Duwe S
    Pediatr Infect Dis J; 2012 Sep; 31(9):899-905. PubMed ID: 22581220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in children.
    Stephenson I; Democratis J; Lackenby A; McNally T; Smith J; Pareek M; Ellis J; Bermingham A; Nicholson K; Zambon M
    Clin Infect Dis; 2009 Feb; 48(4):389-96. PubMed ID: 19133796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Memory CD4 T cells direct protective responses to influenza virus in the lungs through helper-independent mechanisms.
    Teijaro JR; Verhoeven D; Page CA; Turner D; Farber DL
    J Virol; 2010 Sep; 84(18):9217-26. PubMed ID: 20592069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Vaccination on Distribution of T Cell Subsets in Antiretroviral-Treated HIV-Infected Children.
    Thitilertdecha P; Khowawisetsut L; Ammaranond P; Poungpairoj P; Tantithavorn V; Onlamoon N
    Dis Markers; 2017; 2017():5729639. PubMed ID: 28694558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
    Walz L; Kays SK; Zimmer G; von Messling V
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1 feeding enhances humoral immune responses, which are suppressed by the antiviral neuraminidase inhibitor oseltamivir in influenza A virus-infected mice.
    Takahashi E; Sawabuchi T; Kimoto T; Sakai S; Kido H
    J Dairy Sci; 2019 Nov; 102(11):9559-9569. PubMed ID: 31495632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aerosol Delivery of a Candidate Universal Influenza Vaccine Reduces Viral Load in Pigs Challenged with Pandemic H1N1 Virus.
    Morgan SB; Hemmink JD; Porter E; Harley R; Shelton H; Aramouni M; Everett HE; Brookes SM; Bailey M; Townsend AM; Charleston B; Tchilian E
    J Immunol; 2016 Jun; 196(12):5014-23. PubMed ID: 27183611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Hemagglutinin A Stem Antibody MEDI8852 Prevents and Controls Disease and Limits Transmission of Pandemic Influenza Viruses.
    Paules CI; Lakdawala S; McAuliffe JM; Paskel M; Vogel L; Kallewaard NL; Zhu Q; Subbarao K
    J Infect Dis; 2017 Aug; 216(3):356-365. PubMed ID: 28633457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.